The 9-year-old Hinge Health offers a digital solution to treat chronic musculoskeletal (MSK) conditions and was last valued at $6.2 billion in October 2021.
The company touts that it is "now one of the most valuable companies in digital health."
Hello and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unpack the numbers behind the headlines. Danny, Natasha, and Alex were on deck this week, with Grace on th
SWORD Health, a virtual musculoskeletal care platform founded in 2015, announced today that it has raised an $85 million Series C funding round led by General Catalyst. Other participating investors i
Board tensions at Hinge Health, a San Francisco-based digital health unicorn, have caused Bessemer Venture Partners to switch up its board director seat, replacing the original investor at the chair w
Hinge Health, the San Francisco-based company that offers a digital solution to treat chronic musculoskeletal (MSK) conditions — such as back and joint pain — has closed a $300 million in Series D
As part of Disrupt 2020 we wanted to look at the contrasting positions of both early and later-stage investing in Europe. Who better to unpack this subject than two highly experienced operators in the
Carolina Brochado, the former Atomico partner and most recently a partner at SoftBank Vision Fund’s London office, has joined EQT to help launch a new fund dedicated to growth-stage investments,
Hinge Health, the San Francisco-based startup that offers a digital solution to treat chronic musculoskeletal (MSK) conditions — such as back and joint pain — has closed a $90 million Series C. Th
Hinge Health, the San Francisco-based startup that offers a tech-enabled platform to treat musculoskeletal (MSK) disorders — things like knee pain, shoulder pain, or back pain — has raised $26
<a target="_blank" href="http://hingehealth.com/">Hinge Health</a>, a startup originally founded out of London but that has since moved its headquarters to San Francisco, is on mission to "digitize th